Biopharma and life sciences companies strengthened their leadership teams and boards with these personnel appointments.

Shares of Vertex Pharmaceuticals fell in trading after the company announced it will not advance a novel small molecule corrector of the Z-AAT protein into a Phase III study for a rare disease that can lead to complications of the liver and lungs.

The United States will continue to press for a waiver of intellectual property rights for Covid-19 vaccines and treatments even as it and other Group of Seven rich nations sharply expand donations of vaccines to poorer countries.

The United States on June 10 raised the pressure on other Group of Seven (G7) leaders to share their vaccine hoards to bring an end to the pandemic by pledging to donate 500 million doses of the Pfizer coronavirus vaccine to the world’s poorest countries.

Ocugen had to change the Pennsylvania-based eye disease company’s application for the Covid-19 vaccine Covaxin from an Emergency Use Authorization to a full Biologics License Application (BLA) approval. 

Across the pharmaceutical industry, forging collaborations are a key tool to bringing new medications through the clinic and to market. This week, multiple companies have partnered in attempts to bring forth new therapies. BioSpace took a look at some of these announcements.

Johnson & Johnson said on June 10 the U.S. Food and Drug Administration extended the shelf life of the company’s single-shot Covid-19 vaccine from three months to four-and-a-half months, as millions of unused doses nationwide near expiration.

Med Ad News caught up with David Ormesher, CEO of closerlook, and Ross Toohey, chief commercialization officer of Fishawack Health, to talk about Fishawack’s acquisition of closerlook, what made the deal so attractive on both ends, and what the acquisition promises for clients.

Ashfield Advisory, an ecosystem of healthcare advisory and consulting businesses and part of UDG Healthcare plc., announced two senior leadership appointments.

In a $7 billion transaction, San Francisco-based Datavant is merging with data network company Ciox Health to create the nation’s largest “neutral and secure health data ecosystem.”